|
|
|
|
||
Re: SGMO (SM) doesn’t plan to share patient-by-patient or cohort-by-cohort dataI can't help but think Sandy will be challenged to provide further color as to his rationale behind this pivotal decision to censor interim HemoB results by one of our covering analysts on the conference call. Will be interesting to see if so, and whether any opening on his part that they may reconsider... |
return to message board, top of board |